NIAID Banner Logo Image

Other Viruses Citation List: February 28 - March 13, 2014

Hepatitis B Virus

1. Isothiafludine, a Novel Non-nucleoside Compound, Inhibits Hepatitis B Virus Replication through Blocking Pregenomic RNA Encapsidation. Yang, L., L.P. Shi, H.J. Chen, X.K. Tong, G.F. Wang, Y.M. Zhang, W.L. Wang, C.L. Feng, P.L. He, F.H. Zhu, Y.H. Hao, B.J. Wang, D.L. Yang, W. Tang, F.J. Nan, and J.P. Zuo. Acta Pharmacologica Sinica, 2014. 35(3): p. 410-418; PMID[24487969].

[PubMed]. OV_0228-03131414.

Hepatitis C Virus

2. New Drug for Hepatitis C Infection. Aschenbrenner, D.S. The American Journal of Nursing, 2014. 114(3): p. 23; PMID[24572531].

[PubMed]. OV_0228-03131414.


3. Efficacy of Nucleotide Polymerase Inhibitor Sofosbuvir Plus the NS5A Inhibitor Ledipasvir or the NS5B Non-Nucleoside Inhibitor GS-9669 against HCV Genotype 1 Infection. Gane, E.J., C.A. Stedman, R.H. Hyland, X. Ding, E. Svarovskaia, G.M. Subramanian, W.T. Symonds, J.G. McHutchison, and P.S. Pang. Gastroenterology, 2014. 146(3): p. 736-743; PMID[24262278].

[PubMed]. OV_0228-03131414.


4. Inhibition of Hepatitis C Virus Infection by DNA Aptamer against NS2 Protein. Gao, Y., X. Yu, B. Xue, F. Zhou, X. Wang, D. Yang, N. Liu, L. Xu, X. Fang, and H. Zhu. Plos One, 2014. 9(2): p. e90333; PMID[24587329].

[PubMed]. OV_0228-031314.


5. 4'-Substituted Pyrimidine Nucleosides Lacking 5'-Hydroxyl Function as Potential anti-HCV Agents. Shakya, N., S. Vedi, C. Liang, F. Yang, B. Agrawal, and R. Kumar. Bioorganic & Medicinal Chemistry Letters, 2014. 24(5): p. 1407-1409; PMID[24485784].

[PubMed]. OV_0228-031314.

Feline Immunodeficiency Virus

6. Antiviral Efficacy of Nine Nucleoside Reverse Transcriptase Inhibitors against Feline Immunodeficiency Virus in Feline Peripheral Blood Mononuclear Cells. Schwartz, A.M., M.A. McCrackin, R.F. Schinazi, P.B. Hill, T.W. Vahlenkamp, M.B. Tompkins, and K. Hartmann. American Journal of Veterinary Research, 2014. 75(3): p. 273-281; PMID[24564313].

[PubMed]. OV_0228-031314.

Herpes Simplex Virus 1

7. Topical Application of Polyethylenimine as a Candidate for Novel Prophylactic Therapeutics against Genital Herpes Caused by Herpes Simplex Virus. Hayashi, K., H. Onoue, K. Sasaki, J.B. Lee, P.K. Kumar, S.C. Gopinath, Y. Maitani, T. Kai, and T. Hayashi. Archives of Virology, 2014. 159(3): p. 425-435; PMID[24046087].

[PubMed]. OV_0228-031314.


8. Formulation of Abalone Hemocyanin with High Antiviral Activity and Stability. Zanjani, N.T., F. Sairi, G. Marshall, M.M. Saksena, P. Valtchev, V.G. Gomes, A.L. Cunningham, and F. Dehghani. European Journal of Pharmaceutical Sciences, 2014. 53: p. 77-85; PMID[24275606].

[PubMed]. OV_0228-031314.

Citations from the ISI Web of Knowledge Listings for O.V.

9. Novel Cell-based Hepatitis C Virus Infection Assay for Quantitative High-throughput Screening of anti-Hepatitis C Virus Compounds. Hu, Z.Y., K.H. Lan, S.S. He, M. Swaroop, X. Hu, N. Southall, W. Zheng, and T.J. Liang. Antimicrobial Agents and Chemotherapy, 2014. 58(2): p. 995-1004; ISI[000330637500045].

[WOS]. OV_0228-031314.


10. Synthesis and Evaluation of Hexahydropyrimidines and Diamines as Novel Hepatitis C Virus Inhibitors. Hwang, J.Y., H.Y. Kim, S. Jo, E. Park, J. Choi, S. Kong, D.S. Park, J.M. Heo, J.S. Lee, Y. Ko, I. Choi, J. Cechetto, J. Kim, J. Lee, Z. No, and M.P. Windisch. European Journal of Medicinal Chemistry, 2013. 70: p. 315-325; ISI[000330554400027].

[WOS]. OV_0228-031314.


11. A Novel Uridine Nucleotide Prodrug, IDX20963, and Its Potential for Use in a Low-dose Direct-acting Antiviral Regimen for HCV. Lallos, L., X.R. Pan-Zhou, J. McCarville, S.Q. Luo, I. Serra, H. Rashidzadeh, M. LaColla, B. Hernandez-Santiago, J.P. Bilello, C. Chapron, F. Danehy, A.N. Allen, M. Camire, M. Seifer, K.S. Gupta, J.F. Griffon, C.C. Parsy, F.R. Alexandre, C.B. Dousson, N.L. Golitsina, S. Bhadresa, U. Miner, R. Rush, and D.N. Standring. Hepatology, 2013. 58: p. 441A-442A; ISI[000330252202089].

[WOS]. OV_0228-031314.


12. Evaluation of Second-generation NS5A Inhibitors against Hepatitis C Virus by Using NS5A Replaced JFH-1 Viruses and Full-length Infectious Clones Other Than JFH-1. Murayama, A., N. Sugiyama, T. Wakita, and T. Kato. Hepatology, 2013. 58: p. 439A-439A; ISI[000330252202084].

[WOS]. OV_0228-031314.


13. IFN-Alpha and RBV Combination Synergistically Inhibit HCV IRES Translation at the Level of Polyribosome Formation. Panigrahi, R., S. Hazari, S. Chandra, P.K. Chandra, C.E. Cameron, Z.H. Huang, L.A. Balart, and S. Dash. Hepatology, 2013. 58: p. 937A-938A; ISI[000330252204289].

[WOS]. OV_0228-031314.


14. Microsomal Triglyceride Transfer Protein (MTP) Inhibitors Efficiently Block the Production of Infectious Hepatitis C Virus (HCV) in Primary Human Adult Hepatocytes. Pene, V.M. and A.R. Rosenberg. Hepatology, 2013. 58: p. 931A-931A; ISI[000330252204275].

[WOS]. OV_0228-031314.


15. HMG-CoA Reductase Inhibition Alters the Lipidome and Infectious Properties of HCV Virus Particles. Peng, L.F., J. Meixiong, A. Deik, E.A. Schaefer, N. Jilg, P. Chusri, C. Brisac, S. Chevaliez, C.L. Zhu, J. Luther, D. Wambua, D.N. Fusco, W.Y. Lin, C.B. Clish, and R.T. Chung. Hepatology, 2013. 58: p. 936A-936A; ISI[000330252204286].

[WOS]. OV_0228-031314.


16. Quercetin Inhibits HCV Replication by Modulating Lipid Droplets Morphology and Core Protein Co-Localization. Rojas, A., J.A. Del Campo, M. Garcia-Valdecasas, S. Clement, F. Negro, and M. Romero-Gomez. Hepatology, 2013. 58: p. 926A-926A; ISI[000330252204264].

[WOS]. OV_0228-031314.


17. Phosphoramidate Prodrugs of beta-D-2'-C-Me-2,6-diaminopurine ribonucleoside are Potent Inhibitors of Hepatitis C Virus (HCV) Replication Delivering Two Active Nucleoside Triphosphates. Schinazi, R.F., L.H. Zhou, H.W. Zhang, M. Ehteshami, S.J. Tao, L.C. Bassit, J. Suesserman, T. Whitaker, T.R. McBrayer, J.H. Cho, S. Amiralaei, J. Shelton, M. Detorio, and S. Coats. Hepatology, 2013. 58: p. 437A-437A; ISI[000330252202080].

[WOS]. OV_0228-031314.


18. Tributyltin(IV) 3-(3',5'-Dimethylphenylamido)propanoate as a Potent HCV Inhibitor, Its Delivery Study, Controlled Release and Binding Sites Using CTAB as a Standard Cell Membrane. Shah, F.A., K. Fatima, S. Sabir, S. Ali, and I. Qadri. Applied Organometallic Chemistry, 2014. 28(2): p. 74-80; ISI[000331128000003].

[WOS]. OV_0228-031314.


19. A Cyclic Retinoid, Peretinoin, Inhibits Hepatitis C Virus Replication in Cell Culture. Shimakami, T., M. Honda, T. Shirasaki, S.M. Lemon, and S. Kaneko. Hepatology, 2013. 58: p. 930A-930A; ISI[000330252204272].

[WOS]. OV_0228-031314.


20. Preclinical Characteristics of ACH-3422: A Potent Uridine Nucleotide Prodrug for Inhibition of Hepatitis C Virus Polymerase. Yang, W.G., J. Wiles, D. Patel, S. Podos, J.L. Fabrycki, Y.S. Zhao, L.L. Jia, G.W. Yang, J.O. Rivera, M. Elliot, C. Marlor, A. Hashimoto, G. Pais, V. Gadachanda, X.Z. Wang, D.W. Chen, Q.P. Wang, M. Deshpande, M.J. Huang, K. Stauber, and A. Phadke. Hepatology, 2013. 58: p. 436A-437A; ISI[000330252202079].

[WOS]. OV_0228-031314.


21. Antiviral Toxicity and PK Studies of Novel Picomolar Potent HCV NS5A Inhibitors. Zhan, Z.Y.J., X.D. Wu, and H. Yan. Hepatology, 2013. 58: p. 938A-938A; ISI[000330252204290].

[WOS]. OV_0228-031314.


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2024